Corbus Pharmaceuticals (CRBP) PT Raised to $57 at Oppenheimer
Tweet
Share
E-mailGet Alerts CRBP Hot Sheet
Price: $9.38 +4.22%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 82
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 82
Join SI Premium – FREE
Oppenheimer analyst Jeff Jones raised the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $57.00 (from $53.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Intercontinental Exchange (ICE) PT Lowered to $190 at UBS Following June Metrics Release
- AppLovin Corp (APP) PT Raised to $575 at Wells Fargo
- Rivian Automotive Inc (RIVN) PT Raised to $17 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
